Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence

Gynecologic Oncology

Volumn 123, Issue 2, 2011, Pages 253-256

  Ho, Kung Chu ^a   Wang, Chun Chieh ^a   Qiu, Jian Tai ^a   Lai, Chyong Huey ^a   Hong, Ji Hong ^a   Huang, Yi Ting ^a   Huang, Kuan Gen ^a   Chao, Angel ^a   Lin, Gigin ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cervical cancer; FDG PET; Recurrence; Supraclavicular lymph nodes

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LATENT PERIOD; LYMPH NODE METASTASIS; MEDICAL DOCUMENTATION; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RECURRENCE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 80054724206     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.07.020     Document Type: Article

References (22)

1. C. Vale, J.F. Tierney, and L.A. Stewart Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
2. J.H. Hong, C.S. Tsai, and C.H. Lai Recurrent squamous cell carcinoma of cervix after definitive radiotherapy Int J Radiat Oncol Biol Phys 60 2004 249 257
3. B.N. Tran, P.W. Grigsby, F. Dehdashti, T.J. Herzog, and B.A. Siegel Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix Gynecol Oncol 90 2003 572 576
4. J.T. Qiu, K.C. Ho, and C.H. Lai Supraclavicular lymph node metastases in cervical cancer Eur J Gynaecol Oncol 28 2007 33 38
5. E.A. Kidd, B.A. Siegel, and F. Dehdashti Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis J Clin Oncol 28 2010 2108 2113
6. C.K. Chung, W.A. Nahhas, J.A. Stryker, and R. Mortel Treatment outcome of recurrent cervical cancer J Surg Oncol 24 1983 5 10
7. K. Shiromizu, T. Kasamatsu, T. Honma, K. Matsumoto, T. Shirai, and M. Takahashi Clinicopathological study of recurrent uterine cervical squamous-cell carcinoma J Obstet Gynaecol Res 25 1999 395 399
8. H. Sakurai, N. Mitsuhashi, and M. Takahashi Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone: patterns of recurrence, latent periods, and prognosis Int J Radiat Oncol Biol Phys 50 2001 1136 1144
9. 18F]fluoro-2-deoxy-D-glucose positron emission tomography Cancer 100 2004 544 552
10. 18F-FDG PET for recurrent cervical cancer J Nucl Med 45 2004 1632 1639
11. 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer Eur J Nucl Med Mol Imaging 33 2006 1399 1407
12. 18F-FDG PET J Nucl Med 49 2008 1936 1943
13. F. Xue, L.L. Lin, F. Dehdashti, T.R. Miller, B.A. Siegel, and P.W. Grigsby F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 2006 147 151
14. T.C. Yen, L.C. See, and C.H. Lai Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer Eur J Nucl Med Mol Imaging 35 2008 493 501
15. T.C. Yen, K.K. Ng, and S.Y. Ma Value of dual-phase 2-fluoro-2-deoxy-d- glucose positron emission tomography in cervical cancer J Clin Oncol 21 2003 3651 3658
16. B. Brandt 111, and S. Lifshitz Scalene node biopsy in advanced carcinoma of the cervix uteri Cancer 47 1981 1920 1921
17. J.H. Hong, C.S. Tsai, and C.H. Lai Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone Int J Radiat Oncol Biol Phys 63 2005 492 499
18. A. Gadducci, R. Tana, S. Cosio, and A.R. Genazzani The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature Crit Rev Oncol Hematol 66 2008 10 20
19. P.W. Grigsby, B.A. Siegel, and F. Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 2001 3745 3749
20. E.A. Kidd, B.A. Siegel, F. Dehdashti, and P.W. Grigsby The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 2007 1738 1744
21. A.K. Elizabeth, A.S. Barry, D. Farrokh, and W.G. Perry Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer Cancer 116 2010 1469 1475
22. N.P. Rizk, L. Tang, and P.S. Adusumilli Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma J Thorac Oncol 4 2009 875 879